Contact Us



ICH Regulation and Compliance in China: Get ready Today for Tomorrow

August 01, 2018 | 9:00 – 10:00AM China Time

Presented by:
Ye Zha, Business Director, ArisGlobal, and Chuck Cheng Zhu, Head of PV, R&G





Leading the way with innovative and disruptive technology to transcends all traditional Pharmacovigilance process



Press Release:

Celegence and ArisGlobal Partner on RIMS and IDMP Business Process-as-a-Service Offering

Press Release:

APCER Life Sciences and ArisGlobal launches Multi-tenant LifeSphere® Safety MultiVigilance for Global Pharmacovigilance

LifeSphere Platform

Clinical Development

Clinical Development provides solutions for clinical operations combined with clinical data management to offer the most complete clinical research platform in the industry.

Regulatory Affairs

Regulatory Affairs is a suite of next generation solutions for regulatory compliance that integrates compliance with business processes over the entire product management lifecycle.

PV & Safety

Pharmacovigilance & Risk Management offers a modern clinical safety and PV platform to improve compliance with global regulatory guidelines.

Medical Affairs

Medical Affairs platform offers a complete suite solutions for pre and post-marketing communications between internal and external stakeholders.


How far along are you in realizing benefits from automation? What is the biggest hindrance in adopting automation technologies? This two-part blog series analyzes polling responses from a recent DIA w...


Compliance with the new General Data Protection Regulation (GDPR), scheduled to become effective 25th May 2018, applies to all organizations that control or process personal data of European Union (EU...

White Paper

One of today’s big conversations in clinical research is how the conventional approach for monitoring trial conduct simply doesn’t give the best view of data. Download this whitepaper which descri...

White Paper

During a recent webcast, ArisGlobal carried out an insightful survey, which found that visibility and reporting inefficiencies remain a headache....